de Jong Marion, Van Laere Koen
Departments of Nuclear Medicine and Radiology, Erasmus MC Rotterdam, Rotterdam, The Netherlands,
Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):781-802. doi: 10.1007/s00259-014-2986-1. Epub 2015 Feb 17.
The EANM Congress 2014 took place in Gothenburg, Sweden, from 18 to 22 October under the presidency of Prof. Wim Oyen, chair of the EANM Scientific Committee. Prof. Peter Gjertsson chaired the Local Organizing Committee, according to the standardized EANM congress structure. The meeting was a highlight for the multidisciplinary community that forms the heart and soul of nuclear medicine; attendance was exceptionally high. In total almost 5,300 participants came to Gothenburg, and 1,397 colleagues participated via the EANM LIVE sessions ( http://eanmlive.eanm.org/index.php ). Participants from all continents were presented with an excellent programme consisting of symposia, scientific and featured sessions, CME sessions, and plenary lectures. These lectures were devoted to nuclear medicine therapy, hybrid imaging and molecular life sciences. Two tracks were included in the main programme, clustering multi-committee involvement: the 5th International Symposium on Targeted Radionuclide-therapy and Dosimetry (ISTARD) and the first Molecules to Man (M2M) track, an initiative of the EANM Committees for Translational Molecular Imaging, Radiopharmacy and Drug Development. The industry made a substantial contribution to the success of the congress demonstrating the latest technology and innovations in the field. During the closing Highlights Lecture, a selection of the best-rated abstracts was presented including diverse areas of nuclear medicine: physics and instrumentation, radiopharmacy, preclinical imaging, oncology (with a focus on the clinical application of newly developed tracers) and radionuclide therapy, cardiology and neurosciences. This Highlights Lecture could only be a brief summary of the large amount of data presented and discussed during the meeting, which can be found in much greater detail in the congress proceedings book, published as Volume 41, Supplement 2 of the European Journal of Nuclear Medicine and Molecular Imaging in October 2014.
2014年欧洲核医学协会（EANM）大会于10月18日至22日在瑞典哥德堡举行，由EANM科学委员会主席维姆·奥扬教授担任主席。按照EANM大会的标准化结构，彼得·耶特松教授担任当地组织委员会主席。此次会议对于构成核医学核心与灵魂的多学科群体而言是一大亮点；参会人数异常之多。总共有近5300名与会者来到哥德堡，1397名同事通过EANM直播会议（http://eanmlive.eanm.org/index.php）参与。来自各大洲的与会者都获得了一份精彩的会议议程，包括专题研讨会、科学及特色会议、继续医学教育（CME）会议以及全会讲座。这些讲座聚焦于核医学治疗、混合成像和分子生命科学。主要议程包含两条线路，整合了多个委员会的参与：第五届靶向放射性核素治疗与剂量测定国际研讨会（ISTARD）以及首个“从分子到人体”（M2M）线路，这是EANM转化分子成像委员会、放射性药物学委员会和药物研发委员会发起的一项活动。业界为大会的成功做出了重大贡献，展示了该领域的最新技术与创新成果。在闭幕亮点讲座中，展示了一系列评选出的最佳摘要，涵盖核医学的多个不同领域：物理与仪器、放射性药物学、临床前成像、肿瘤学（重点关注新开发示踪剂的临床应用）以及放射性核素治疗、心脏病学和神经科学。本次亮点讲座只能是对会议期间展示和讨论的大量数据的简要总结，这些数据在2014年10月作为《欧洲核医学与分子成像杂志》第41卷增刊2出版的会议论文集中有更详细的内容。
Zotero 插件
